A new psychedelic ‘miracle drug’ can treat depression and post-traumatic stress disorder without hallucinations.
Psychedelic has long been shown to promise a cure for mental illness, and now scientists have identified only beneficial compounds.
US researchers say AAZ-A-154, which has the potential to repair brain chemical pathways.
Study co-author Dr. David Olson, a chemist at the University of California, Davis explains, “One of the problems with psychedelic therapy is that they need advice and close supervision from a medical team … home.”
An experiment using a fluorescent sensor called cyclolite found that a new drug activates a gene that produces serotonin, the body’s ‘feel-good’ hormone.
The most common antidepressants, such as Prozac, also work by stimulating 2A serotonin receptors.
over: Magnetic brain treatment was found to relieve depression symptoms in 90% of the participants without negative side effects.
The study, published in the journal Cell, found no hallucinogenic effects of AAZ-A-154 – so it’s not obnoxious.
Experts believe one of the benefits of psychedelic drugs is that they promote neural plasticity, which allows the brain to adjust itself. This opens the door to a single-dose or small-dose drug, rather than having to be taken over and over.
Mental illness affects billions of people worldwide, with depression being the most common type, destroying 250 million lives. The “psychedelic journey” raises ethical and health concerns.
For example, previous research has shown that psilocybin, a constituent of the psychedelic ‘magic mushroom’, reduces symptoms quickly. But also causes side effects
Check-out: Could a mild ‘depression’ be good for you? An enlightened look at ‘Epidemic’
The AAZ-A-154 is without a ‘journey.’ It’s definitely hopeful news, and we’ll post updates to this story as they come in.
Send this research to your friends by sharing on social media …